-lim-
idiospecific
ocrelizumab
-o-
reagin
conatumumab
heterophile antibody
Forssman antibody
heterophil antibody
atezolizumab
panitumumab
-ab
evolocumab
immunospecific
drozitumab
oleclumab
heterophile
zolimomab
alloantibody
bezlotoxumab
siltuximab
immunoprobe
biciromab
robatumumab
sulesomab
olendalizumab
bococizumab
onartuzumab
Ab
monoclonal
dacetuzumab
-a-
pancytokeratin
antiantibody
antigenic
iratumumab
matuzumab
antisynthetase
countercorrelated
lintuzumab
inotuzumab ozogamicin
intrabody
antigenomic
agonistic monoclonal antibody
tabalumab
ABO antibodies
brentuximab
immunonaive
polyantibody
-i-